Literature DB >> 10211307

A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy.

A de Graeff1, J R de Leeuw, W J Ros, G J Hordijk, G H Blijham, J A Winnubst.   

Abstract

The aim of this study was to describe prospectively quality of life and mood in patients with oral or oropharyngeal cancer treated with surgery +/- radiotherapy. Seventy-five patients completed the EORTC Core Questionnaire, the EORTC Head and Neck Cancer module and the Center for Epidemiologic Studies' Depression Scale before treatment and 6 and 12 months later. There was a significant deterioration of physical functioning, fatigue and almost all head and neck symptoms except pain, which improved. Patients with stage III/IV and patients receiving combined treatment had significantly worse physical symptoms compared to patients with stage I/II and patients treated with surgery only, respectively. Before and after treatment there was a high level of depressive symptomatology. However, after treatment a gradual improvement in emotional functioning occurred. Surgical treatment for oral or oropharyngeal cancer results in significant deterioration of physical functioning and symptoms during the first year, especially when combined with radiotherapy. Despite this, there is an improvement of emotional functioning after treatment, probably as a result of adaptation and coping processes.

Entities:  

Mesh:

Year:  1999        PMID: 10211307     DOI: 10.1016/s1368-8375(98)00049-9

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  31 in total

1.  Quality of life in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C30, H and N35).

Authors:  Juan Ignacio Arraras Urdaniz; Fernando Arias de la Vega; Ana Manterola Burgaleta; Ruth Vera García; Maite Martínez Aguillo; Esteban Salgado Pascual; Enrique Martínez López
Journal:  Clin Transl Oncol       Date:  2005-10       Impact factor: 3.405

2.  Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  H B Zhang; X Lu; S M Huang; L Wang; C Zhao; W X Xia; S W Li; F L Wang; Y L Zhu; X Guo; Y Q Xiang
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

3.  Long-term functional outcomes and patient perspective following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer.

Authors:  Bena Cartmill; Petrea Cornwell; Elizabeth Ward; Wendy Davidson; Sandro Porceddu
Journal:  Dysphagia       Date:  2012-02-24       Impact factor: 3.438

Review 4.  Head and neck cancer pain: systematic review of prevalence and associated factors.

Authors:  Tatiana V Macfarlane; Tanja Wirth; Sriyani Ranasinghe; Kim W Ah-See; Nick Renny; David Hurman
Journal:  J Oral Maxillofac Res       Date:  2012-04-01

5.  Predictors of health-related quality of life in patients treated with neck dissection for head and neck cancer.

Authors:  Elise M Gane; Steven M McPhail; Anna L Hatton; Benedict J Panizza; Shaun P O'Leary
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-22       Impact factor: 2.503

6.  Health-Related Quality of Life following Reconstruction for Common Head and Neck Surgical Defects.

Authors:  Wess A Cohen; Claudia R Albornoz; Peter G Cordeiro; Jennifer Cracchiolo; Elizabeth Encarnacion; Meghan Lee; Michele Cavalli; Snehal Patel; Andrea L Pusic; Evan Matros
Journal:  Plast Reconstr Surg       Date:  2016-12       Impact factor: 4.730

7.  [Preoperative radiochemotherapy for advanced oral cavity tumours : the Kiel DOSAK experience regarding curability and quality of life].

Authors:  Jürgen Schultze; Helge Schillmöller; J Camilo Roldán; Jörg Wiltfang; Bernhard Kimmig
Journal:  Mund Kiefer Gesichtschir       Date:  2006-07

Review 8.  A systematic review of orofacial pain in patients receiving cancer therapy.

Authors:  Joel B Epstein; Catherine Hong; Richard M Logan; Andrei Barasch; Sharon M Gordon; Loree Oberle-Edwards; Lorree Oberlee-Edwards; Deborah McGuire; Joel J Napenas; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-06-11       Impact factor: 3.603

9.  Application of the International Classification of Functioning, Disability and Health (ICF) to people with dysphagia following non-surgical head and neck cancer management.

Authors:  Rebecca L Nund; Nerina A Scarinci; Bena Cartmill; Elizabeth C Ward; Pim Kuipers; Sandro V Porceddu
Journal:  Dysphagia       Date:  2014-08-07       Impact factor: 3.438

Review 10.  Current status and perspectives of brachytherapy for head and neck cancer.

Authors:  Hitoshi Shibuya
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.